Electron Kebebew

Electron Kebebew

General Surgery

965 High St
Palo Alto, CA 94301

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 274 publications

Anaplastic thyroid cancer: genomic landscape, molecular drivers and novel therapeutics.

Anaplastic thyroid cancer: genomic landscape, molecular drivers and novel therapeutics.

Journal: Nature reviews. Endocrinology

Published: July 31, 2026

End-Organ Damage Associated With Primary Hyperparathyroidism.

End-Organ Damage Associated With Primary Hyperparathyroidism.

Journal: JAMA surgery

Published: July 29, 2026

CRISPR-Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer.

CRISPR-Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer.

Journal: Molecular carcinogenesis

Published: March 25, 2026

Workforce growth without reach: National trends in access to high-volume parathyroid surgeons.

Workforce growth without reach: National trends in access to high-volume parathyroid surgeons.

Journal: Surgery

Published: December 15, 2025

Corrigendum to "Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis" [Cancer Letters 633 (2025) 217990].

Corrigendum to "Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis" [Cancer Letters 633 (2025) 217990].

Journal: Cancer letters

Published: November 28, 2025

Succinate Dehydrogenase-Deficient Cancer Cells Have Increased Susceptibility to Ym155 Induced DNA Damage.

Succinate Dehydrogenase-Deficient Cancer Cells Have Increased Susceptibility to Ym155 Induced DNA Damage.

Journal: bioRxiv : the preprint server for biology

Published: November 19, 2025

Succinate dehydrogenase-deficient cancer cells have increased susceptibility to Ym155-induced DNA damage.

Succinate dehydrogenase-deficient cancer cells have increased susceptibility to Ym155-induced DNA damage.

Journal: Endocrine-related cancer

Published: October 03, 2025

Utilization of thyroid ultrasound and surgery after glucagon-like peptide-1 receptor agonist prescription.

Utilization of thyroid ultrasound and surgery after glucagon-like peptide-1 receptor agonist prescription.

Journal: Surgery

Published: September 09, 2025

Dual targeting of BRAFV600E and ferroptosis results in synergistic anticancer activity via iron overload and enhanced oxidative stress.

Dual targeting of BRAFV600E and ferroptosis results in synergistic anticancer activity via iron overload and enhanced oxidative stress.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 31, 2025

CRISPR-Based Gene Dependency Screens reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer.

CRISPR-Based Gene Dependency Screens reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer.

Journal: bioRxiv : the preprint server for biology

Published: July 16, 2025

Dual Targeting of BRAF V600E and Ferroptosis Results in Synergistic Anticancer Activity via Iron Overload and Enhanced Oxidative Stress.

Dual Targeting of BRAF V600E and Ferroptosis Results in Synergistic Anticancer Activity via Iron Overload and Enhanced Oxidative Stress.

Journal: bioRxiv : the preprint server for biology

Published: July 16, 2025

Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis.

Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis.

Journal: Cancer letters

Published: May 27, 2025

Showing 1-12 of 274

Last Updated: 09/26/2026